SOPHiA GENETICS SA
Recurring revenueRegulated industrySells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $7.45
- 52-Week Range
- $3.83 – $8.98
- Market Cap
- $639.87M
- P/E (TTM)
- —
- EPS (TTM)
- -1.09
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 9.35
- PEG Ratio
- —
- Return on Equity
- -125.67%
- Return on Assets
- -26.46%
- Gross Margin
- 66.43%
- Operating Margin
- -81.02%
- Profit Margin
- -89.18%
- Current Ratio
- 2.29
- Debt/Equity
- 0.89
- Total Debt
- $61.04M
- Free Cash Flow
- $-25.56M
- Revenue Growth
- 24.70%
- Earnings Growth
- —
- Enterprise Value
- $607.26M
Market Snapshot
About
SOPHiA GENETICS is a healthcare technology company that applies artificial intelligence and data analytics to genomic and multimodal data. The company operates a cloud-based platform that helps hospitals, laboratories, and biopharma institutions analyze complex genomic information for clinical diagnostics and drug development. SOPHiA GENETICS focuses on oncology, rare diseases, and other genetic conditions.